GLICK GARY D (See Remarks) reported 1 transaction at ODYSSEY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/12/2026ACC: 0001193125-26-217585
DirectorOfficer· See Remarks
Since May 2026
+645.72K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
911.84K acquired · 266.12K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+27.39K
Price / share
—
Trade value
—
% of position
7.0%
5/11/2026
388.59K→415.97K
Total
Net shares
+27.39K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | C · Conversion | +27.39K | — | — | 7.0% | 388.59K | 415.97K |
| Total | +27.39K | $0.00 | ||||||
Derivative Transactions3
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
884.45K shares
Shares
+884.45K
Strike price
18.00
Held after
884.45K
Exercisable
—
5/7/2026
Series C Convertible Preferred Stock
Direct
Converts to
Common Stock
10.29K shares
Shares
−100K
Strike price
Held after
0.00
Exercisable
—
5/11/2026
Series D Convertible Preferred Stock
Direct
Converts to
Common Stock
17.09K shares
Shares
−166.12K
Strike price
Held after
0.00
Exercisable
—
5/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock884.45K shares | 5/7/2026 | A · Award | +884.45K | 18.00 | — | 884.45K |
| Series C Convertible Preferred Stock Direct | Common Stock10.29K shares | 5/11/2026 | C · Conversion | −100K | — | 0.00 | |
| Series D Convertible Preferred Stock Direct | Common Stock17.09K shares | 5/11/2026 | C · Conversion | −166.12K | — | 0.00 |